(0.32%) 5 107.75 points
(0.75%) 38 670 points
(0.58%) 17 752 points
(0.06%) $79.00
(-0.20%) $2.03
(0.06%) $2 311.10
(-0.03%) $26.82
(1.78%) $979.70
(-0.16%) $0.931
(-0.61%) $10.92
(-0.24%) $0.796
(0.50%) $91.58
1.12% KRW 13 540
Live Chart Being Loaded With Signals
EuBiologics Co., Ltd., a biopharmaceutical company, develops and supplies vaccines for epidemics and antibiotic resistance in South Korea. It offers Euvchol, an oral cholera prevention vaccine; and CRM197, a diphtheria toxin mutant vaccine...
Stats | |
---|---|
Dzisiejszy wolumen | 346 253 |
Średni wolumen | 566 356 |
Kapitalizacja rynkowa | 494.00B |
EPS | KRW-85.00 ( 2023-09-30 ) |
Last Dividend | KRW0 ( N/A ) |
Next Dividend | KRW0 ( N/A ) |
P/E | -114.13 |
ATR14 | KRW15.93 (0.12%) |
Wolumen Korelacja
EuBiologics Co., Ltd. Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
EuBiologics Co., Ltd. Korelacja - Waluta/Towar
EuBiologics Co., Ltd. Finanse
Annual | 2023 |
Przychody: | KRW69.37B |
Zysk brutto: | KRW32.66B (47.08 %) |
EPS: | KRW-380.79 |
FY | 2023 |
Przychody: | KRW69.37B |
Zysk brutto: | KRW32.66B (47.08 %) |
EPS: | KRW-380.79 |
FY | 2022 |
Przychody: | KRW55.47B |
Zysk brutto: | KRW22.22B (40.06 %) |
EPS: | KRW-30.19 |
Financial Reports:
No articles found.
EuBiologics Co., Ltd.
EuBiologics Co., Ltd., a biopharmaceutical company, develops and supplies vaccines for epidemics and antibiotic resistance in South Korea. It offers Euvchol, an oral cholera prevention vaccine; and CRM197, a diphtheria toxin mutant vaccine. The company also provides customized services for mammalian cell and microbial cell derived biopharmaceuticals in accordance with the clients' project stages, including cell line development, GMP production, validation, and the regulatory support; and operates facilities that manufacture protein-based therapeutics and antibodies. It specializes in manufacturing a range of mammalian cell and microbial cell derived biopharmaceuticals, including recombinant biological products and antibody therapeutics. In addition, the company offers process, formulation, and analytical method development, as well as licensing consulting services; and contract testing services that include lot release, stability, raw material, and method validation testing services. The company was founded in 2010 and is based in Seoul, South Korea.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej